Rickettsia mongolotimonae Infection in South Africa by Pretorius, Anne-Marié & Birtles, Richard J.
DISPATCHES





Anne-Marié Pretorius* and Richard J. Birtles†
We report the first laboratory-confirmed case of
Rickettsia mongolotimonae infection in Africa. The patient
sought treatment for an eschar on his toe; lymphangitis,
severe headaches, and fever subsequently developed.
After a regimen of doxycycline, symptoms rapidly resolved.
R. mongolotimonae infection was diagnosed retrospective-
ly by serologic tests and molecular-based detection of the
organism in biopsy specimens of eschar material.  
R
ickettsioses are infections of emerging medical impor-
tance, particularly in southern Africa, where an
increasing number of cases are being encountered among
both residents and tourists (1). Three Rickettsia species
have been associated with human disease in South Africa
to date. Rickettsia conorii has long been recognized as the
agent of Mediterranean spotted fever, and more recently, a
newly recognized species, R. africae, has been identified
as the agent of African tick-bite fever. In 2002, the first
case report of a patient infected with R. aeschlimannii was
published (2). In addition to these recognized pathogens,
Rickettsia species, including R.  mongolotimonae, have
been detected in human-biting arthropods in Africa. This
species (3) was first encountered in Hyalomma asiaticum
ticks in Inner Mongolia in 1991 (4) but has subsequently
been associated with human infections in southern France
(5) and, perhaps of most relevance to this report, has been
detected in H. truncatum ticks collected from cattle in
Niger (6). This species of tick, which at least during its
immature life stages parasitizes migratory birds, is widely
distributed in many African countries, including South
Africa (7).
The Study
In September 2002, a 34-year-old (HIV-seronegative)
construction worker, working near Ellisras in South
Africa’s Northern Province, discovered a lesion on the
inside of the second toe on his right foot (Figure); subse-
quently, severe headaches and high fever developed. He
was examined at a local hospital and found to have lym-
phangitis extending pretibially from the lesion; as a result
of his other symptoms, he was treated for blood poisoning
with ceftriaxone sodium, 1,000 mg once daily. During the
next 3 days, the lesion at the bite site (noted by the exam-
ining physician) remained very sore, and the patient’s right
inguinal lymph node became enlarged and very painful.
The patient then decided to return to his hometown and
sought treatment from his general practitioner (on day 5
after discovery of the lesion). On examination, the lesion
and lymphangitis were clearly visible on the patient’s toe,
although cellulitis and edema were not observed. His
inguinal lymph node had swollen to 3 cm in diameter, and
he was still febrile (38.5°C). Blood samples were then
obtained as well as a biopsy specimen from the lesion. A
regimen of doxycycline, 100 mg per day orally, for 5 days
was prescribed and 1 day’s dosage was administered. The
next day, the patient was afebrile, and the lymphangitis had
completely resolved. 
In the laboratory, a Giemsa stain of a smear prepared
from the patient’s blood showed activated lymphocytes. A
complete blood count showed thrombocytosis (632 x
103/µL), but all other hematologic parameters were within
the normal range. Biochemical findings showed elevated
levels of alanine transaminase (66 IU/L), blood urea nitro-
gen (7.2 g/L), and triglycerides (2.2 mmol/L); and
decreased levels of chloride (96.3 mmol/L) and albumin
(38g/L); all other tests yielded results within the normal
range. Testing of the patient’s serum with the Weil-Felix
test demonstrated an antibody titer (80) only against the
OX2 Proteus antigen, giving presumptive evidence of a
rickettsial infection. As a result, antirickettsial microim-
munofluorescence testing was performed (8). The serum
did not yield significant immunoglobulin (Ig) M titers
against R. conorii or R. africae antigens, but IgG titers of
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64 were found by using both antigens. DNAwas extracted
from the eschar biopsy specimen by using the QIAamp
Tissue kit (QIAGEN GmbH, Hilden, Germany) according
to the manufacturer’s instructions. This DNA extract was
used as template in a previously described polymerase
chain reaction assay targeting a Rickettsia spp.  rOmpA
fragment (9). An amplification product was obtained from
this extract but not from any concurrently processed con-
trol materials. The amplification product was purified; the
nucleic acid sequences of both strands were then deter-
mined. The sequence obtained from these efforts was
found to share >99% similarity with the corresponding
rOmpA fragment of R. mongolotimonae. 
Conclusions
The combination of clinical and laboratory data yielded
strong evidence that the case described here was an infec-
tion of R. mongolotimonae, the first reported in southern
Africa. A single eschar is also typical of R. conorii infec-
tions, but these are characterized by rash (Mediterranean
spotted fever), which the current patient did not have.
Although R. africae infections manifest only rarely as a
rash, they are typified by multiple eschars (10). This case
description is also very similar to that relating to a French
patient infected with R. mongolotimonae, who had lym-
phangitis and inguinal lymphadenopathy. The serologic
findings indicate exposure to a spotted fever group rick-
ettsia rather than to a specific species within this group, but
the near identity of the rOmpAsequence obtained from the
patient’s eschar to that of R. mongolotimonae provides a
clear indication that this species, rather than other spotted
fever group rickettsiae, was present at the site of the tick
bite. Although no tick was found in association with the
patient’s eschar, his infection may have been acquired
from a H. truncatum, as this species is abundant in the
region of the bushveld where the patient had been working
and is known to feed on humans (11).
Dr. Pretorius is a principal specialist medical scientist and
lecturer at the National Health Laboratory Services, Faculty of
Health Sciences, University of the Free State, Bloemfontein,
South Africa. Her research interests include the clinical and epi-
demiologic features of vector-borne diseases, especially those
caused by rickettsiae, ehrlichiae, and bartonellae.
Dr. Birtles is a senior lecturer at the Centre for Comparative
Infectious Diseases, Department of Veterinary Pathology, Faculty
of Veterinary Science, University of Liverpool, Liverpool, UK.
His research interests include the epidemiology, ecology, and
pathogenicity of bartonellae and other arthropodborne bacteria,
particularly in natural reservoir–vector systems.
References
1. Raoult D, Fournier P-E, Fenollar F, Jensenius M, Prioe T, De Pina JJ,
et al. Rickettsia africae, a tick-borne pathogen of travellers to sub-
saharan Africa. N Engl J Med 2001;344:1504–10.
2. Pretorius A-M, Birtles RJ. Rickettsia aeschlimannii: a new pathogen-
ic spotted fever group rickettsia, South Africa. Emerg Infect Dis
2002;8:874.
3. Raoult D, Brouqui P, Roux V. A new spotted-fever-group rickettsio-
sis. Lancet 1996;348:412.
4. Yu X, Fan M, Xu G, Liu Q, Raoult D. Genotypic and antigenic iden-
tification of two new strains of spotted fever group rickettsiae isolat-
ed from China. J Clin Microbiol 1993;31:83–8.
5. Fournier P-E, Tissot-Dupont H, Gallais H, Raoult D. Rickettsia mon-
golotimonae: a rare pathogen in France. Emerg Infect Dis
2000;6:290–2.
6. Parola P, Inokuma H, Camicas J-L, Brouqui P, Raoult D. Detection
and identification of spotted fever group rickettsiae and ehrlichiae in
African ticks. Emerg Infect Dis 2001;7:1014–7.
7. Walker J. A review of the Ixodid ticks (Acari, Ixodidae) occurring in
southern Africa. Onderstepoort J Vet Res 1991;58:81–105.
8. Teysseire N, Raoult D. Comparison of Western immunoblotting and
microimmunofluorescence for diagnosis of Mediterranean spotted
fever. J Clin Microbiol 1992;30:455–60.
9. Roux V, Fournier P-E, Raoult D. Differentiation of spotted fever
group rickettsiae by sequencing and analysis of restriction fragment
length polymorphism of PCR amplified DNA of the gene encoding
the protein rOmpA. J Clin Microbiol 1996;34:2058–65.
10. Roux V, Raoult D. Rickettsioses as paradigms of new or emerging
infectious diseases. Clin Microbiol Rev 1997;10:694–719.
11. Horak IG, Fourie LJ, Heyne H, Walker JB, Needham GR. Ixodid ticks
feeding on humans in South Africa: with notes on preferred hosts,
geographic distribution, seasonal occurrence and transmission of
pathogens. Exp Appl Acarol 2002;27:113–36.
Address for correspondence: Anne-Marié Pretorius, National Health
Laboratory Services, Department of Medical Microbiology (G4), Faculty
of Health Sciences, University of the Free State, P.O. Box 339,
Bloemfontein, 9300 South Africa; fax: +27-51-444 3437; email:
gnvramp.nd@mail.uovs.ac.za
Dispatches 
Articles should be 1,000–1,500 words and need not be divided into
sections. If subheadings are used, they should be general, e.g., “The
Study” and “Conclusions.” Provide a brief abstract (50 words); ref-
erences (not to exceed 15); figures or illustrations (not to exceed
two); and a brief biographical sketch of first author—both authors
if only two. Dispatches are updates on infectious disease trends and
research. The articles include descriptions of new methods for
detecting, characterizing, or subtyping new or reemerging
pathogens. Developments in antimicrobial drugs, vaccines, or
infectious disease prevention or elimination programs are appropri-
ate. Case reports are also welcome.
All material published in Emerging Infectious Diseases is in the
public domain and may be used and reprinted without special per-
mission; proper citation, however, is appreciated.
The opinions expressed by authors contributing to this journal do
not necessarily reflect the opinions of the Centers for Disease
Control and Prevention or the institutions with which the authors
are affiliated.